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Abstract 
Background: Major depressive disorder is a mental disorder characterized by a pervasive and persistent low mood 
that is accompanied by low self-esteem and loss of interest or pleasure in normally enjoyable activities. Depression 
is associated with multiple immunological disorders. Aim of the present study was to determine correlation between 
percentage of circulating NK cells and major depressive disorder. Materials and Methods: Patients older than 18 
years with the desire to participate were enrolled in this study. For depression evaluation, we used the Hamilton 
Depression Rating Scale and for determination of percentage of NK cells in peripheral blood, flow cytometry 
method was used. Results: Our results showed that in patients with major depressive disorder, numbers of 
circulating NK cells have significantly reduced. Conclusion: According to our findings, depression is associated 
with “immune suppression”. NK cells are important in early phase of immunological surveillance versus viral 
infections and tumors. Indeed, depressive patients are susceptible to cancers and infections. 
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Major depressive disorder (MDD) is a mental 
disorder characterized by a pervasive and persistent 
low mood that is accompanied by low self-esteem 
andloss of interest or pleasure in normally enjoyable 
activities [1]. Psychosomatically, depression is a risk 
factor for many of the major medical illnesses such as 
heart disease, stroke, cancer and viral infections (e.g., 
HIV/AIDS) [2]. According to World Health 
Organization (WHO), by the year 2030 depression 
will cause disability than any other illness [3]. 
Psychoneuroimmunology is the study of the 
interaction between psychological processes, the 
nervous and immune systems of the human body 
[4].The brain and the immune system are the two 
major adaptive systems in the  body that connect each 
other through signaling pathways [5]. Hence, mental 
factors such as depression have been shown to affect 
immune system function, likely through  
immunosuppression and immune activation 
[6].Conversely, several lines of evidence suggest that 
immune system activation via  infectious diseases, 
cancer, and autoimmune disorders is associated with 
the development of behavioural symptoms . The same 
mechanism has been also observed in the context of 
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chronic stress or major depression. These findings 
implicate a role of the immune system in behavioural 
disorders in a wide range of medical illnesses. Finally, 
a paradigm is proposed in which abnormal function   
either in  the hypothalamic-pituitary-adrenal (HPA) 
axis or in the inflammatory response system disrupts 
feedback regulation of both neuroendocrine and 
immune systems  and contributes to the development 
of neuropsychiatric and immunologic disorders [7]. 
Natural killer cells or NK cells are a type of 
cytotoxic lymphocyte  which are critical for the innate 
immune system. The role of NK cells is analogous to 
that of cytotoxic T cells in the vertebrate adaptive 
immune response. NK cells provide rapid responses 
to viral-infected cells and prevent tumor formation, 
acting at around 3 days after infection [8]. NK cells 
are lymphocytes and major members of the innate 
lymphoid cell (ILC) family, which develop from 
CD34+ hematopoietic cells in the bone marrow and 
undergo terminal maturation in secondary lymphoid 
tissues [9]. In humans, NK cells are classically 
identified by the absence of the T cell receptor 
complex and presence of neural cell adhesion 
molecule (denoted CD56 according to the cluster 
designation [CD] system) [10]. The development of 
the antitumor/antivirus activities of NK cells is 
controlled by multiple mechanisms such as direct 
cytotoxic activity against target cells, antibody-
dependent cell-mediated cytotoxicity, secretion of 
Th1-type cytokines, and interactions with dendritic 
cells [11]. So, in the present study we aimed to 
investigate the relationship of NK cells activity in 
patients with major depressive disorder. 
Methods 
Patients. Patients older than 18 years with the 
desire to participate were enrolled in the study. After 
completing the written informed consent prior to the 
study, patients with no history of physical and mental 
disorders were included. The study population was 
selected in Sheikhorraes Clinic of Tabriz University 
of medical sciences between 2013 and 2014 after the 
diagnosis of major depressive disorder according to 
DSM-IV criteria by a psychiatrist. Patients Hamilton 
Depression Inventory was completed and peripheral 
blood NK-cells percentage was investigated in 35 
patients with moderate depression.  Control group are 
35 normal individuals with the age of 18<years with 
no previous history of mental illness and the above 
mentioned process were conducted on this group too. 
Depression evaluation. The Hamilton 
Depression Rating Scale, 17-item version was used by 
the therapist to assess the severity of depression in 
patients. For synchronization of severity of 
depression, patients with a score of 14-17 in the test 
group with moderate depression were selected. 
Percentage of NK cells in peripheral blood 
From each patients with moderate depression and also  
the control group 5-10 ml of blood were collected and 
kept in EDTA tube. For determination of percentage 
of NK cells in peripheral blood, flow cytometry 
method was used in Shahid-Ghazi Hospital of Tabriz 
University of medical sciences. To determine the 
percentage of NK cells, anti-CD56 PE (Coulter 
Immunotech), in a BD FACS calibour flow cytometer 
were used. Control isotype was mouse IgG1 PE (IQ 
company, Netherland). 
Statistical analysis. The data obtained from the 
study were analyzed with statistical software, SPSS-
20. Normal data distribution was assessed by 
Kolmogorov-Smirnov test. P values less than 0.05 
were considered statistically significant. For 
comparing between controls and patients, T-Test was 
used. 
Results 
Statistical analysis showed that mean 
percentage of NK cells in patients (p) was 15.97±6.82 
and in control group (c) were 19.9±8.75 (P 
value=0.04) (Figure 1 and 2). 
Discussion 
In the present study, we recognized that in 
patients with major depressive disorder, numbers of 
circulating NK cells have reduced. For depression 
evaluation, we used the Hamilton Depression Rating 
Scale. For determination of NK cell percentage in 
peripheral blood, flow cytometry method was used. 
Psychoneuroimmunological studies showed 
that stress and depression are associated with reduced 
proliferative responses of immune cells and impaired 
innate and adaptive immunity [12, 13]. In other 
words, depression is associated with “immune 
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suppression”. Zorilla et al. showed that in depressed 
patients, NK cell cytotoxicity and lymphocyte 
proliferation are decreased [14]. There is some 
evidence about immune differences among the 
subtypes and specifies of major depression as defined 
in DSM-III and DSM-IV. Hypothalamic-pituitary axis 
(HPA) dysregulation may vary as a function of 
depression types. For example, a higher percentage of 
patients were diagnosed with major depression with 
psychotic features are dexamethasone nonsuppressors 
compared with patients meeting criteria for major 
depressive disorder without psychotic features [15, 
16]. However, we synchronized the severity of 
patients in this study. Baniyash et al. showed that 
immune suppression is affected by the 
downregulation of the T cell receptor zeta chain, 
which is an important component of signal 
transduction in both NK cells and T cells [17]. In a 
follow-up of up to 19 years, 923 patients with some 
form of depression diagnosed in a psychiatry clinic 
showed a slightly elevated risk of developing cancer 
in comparison with the other members of a cohort of 
143,574 persons who received prescriptions from a 
pharmacy [18]. However, it has become clear that NK 
 
Figure 1. Comparative percentage of peripheral blood NK cells in depressive patients and healthy controls. 
 
 
Figure 2. Flow cytometry plot of circulating NK-cells (anti CD56 PE, a) and related control (mouse IgG1 PE, b). 
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cells interact with various components of the immune 
system, and therefore have the potential to function as 
regulatory cells. While NK cells can assist in 
dendritic cell (DC) maturation and T-cell polarization, 
increasing evidence indicates that NK cells can also 
prevent and limit adaptive (auto) immune responses 
via killing of autologous myeloid and lymphoid cells 
[19]. Evans et al. has found that depressive symptoms 
are associated with decreased NK cell cytotoxicity in 
women with HIV [20]. Cruess et al. showed that 
enhancement of NK cell cytotoxicity are associated 
with the resolution of depressive symptoms [21]. 
Steven and his colleagues reported that in adults with 
major depression, the attenuation of circulating NK-
cell with the increase in NK-cell activity may be   due 
to the effect of compensation.However,further studies 
are warranted in this regard. It seems that the 
depression affects the NK-cell activity apart from its 
effect on the number of circulating NK-cell (CD56). 
Since there are some changes in the immune system 
of people with untreated or undiagnosed depression, 
the need for further treatment of mood disorders are 
required [22]. On the other hand, Farid et al. showed 
that there was no significant difference regarding NK 
cells between major depressed patients and healthy 
control subjects [23]. 
Conclusion 
We showed thatcirculatory numbers of NK 
cells have been diminished in patients with major 
depressive disorder. NK cells are important in early 
phase of immunological surveillance versus viral 
infections and tumors. Indeed, depressive patients are 
susceptible to cancers and infections. We suggest that 
the role of NK-cell in depressive patients should be 
evaluated through inhibitory and excitatory function 
of NK-cells in future studies. 
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